AI Model Promises New Way to Detect Brain

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
203
AI Model Promises New Way to Detect Brain Malignancies

Central nervous system and brain cancers accounted for 248,500 deaths globally in 2022. In America, roughly 90,000 brain tumors are diagnosed annually, with data from the American Cancer Society showing that over 25,000 of these tumors are cancerous. It is projected that there’ll be an estimated 25,400 new cases of central nervous system and brain cancers in 2024.

Estimates also show that roughly one million individuals in the U.S. live with a primary brain tumor, with about 28% of all brain tumors being malignant. Glioblastoma, a fatal form of brain cancer, accounts for 50% of all malignant brain tumors in the country. This cancer has an 8-month median survival rate and a 5-year relative rate of survival of 6.9%.

Now new research has shown how reusing camouflage animal detection and combining it with artificial intelligence can help identify tumors in the brain.

Dr. Arash Yazdanbakhsh, the lead author, stated that this study was the first of its kind to combine deep neural network training and camouflage animal transfer learning to a tumor classification and detection task.

The researchers theorized that there was a similarity between cancerous cells that blend in with surrounding healthy tissue and animals hiding using natural camouflage. They argued that an artificial intelligence network which was trained to find animals in camouflage could also be used to detect tumors from image data from MRI brain scans.

For their study, a repurposed neural network was pretrained to pick out camouflaged animals into 2 artificial intelligence models, one dubbed T2Net to categorize T2-weighted MRIs and the other dubbed T1Net to categorize T1-weighted MRIs.

The brain scan data used for the study was obtained mainly from the Kaggle public databases and the Cancer Imaging Archive. They also used data from normal MRIs to train the neural network as a control.

Gliomas made up a huge share of the brain scan data, with other tumor categories including astrocytomas, oligoastrocytomas, and oligodendrogliomas. The researchers found that transfer learning from the camouflage detection strengthened the AI model’s ability to categorize brain tumors, particularly astrocytomas.

In their report, the researchers revealed that the model demonstrated a strong ability to differentiate between normal and cancerous brains.

They added that this approach to neural network training held potential, particularly when using T2-weighten MRI images, as the model demonstrated the highest improvement in accuracy. The research’s findings were reported in Biology Methods & Protocols.

Other researchers involved in the study include Haluk Ogmen, Faris Rustom, Pedram Parva, and Ezekiel Moroze.

As the detection of brain cancers becomes easier and more accurate, patients can have a chance to quickly get started on the medications being commercialized by companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) targeting different central nervous system malignancies.

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

CNS Pharmaceuticals Inc. (CNSP) Stock Research Links

CNSP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 99

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 27

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 235

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 335

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 254

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 148

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 489

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Albion KAY VCT PLC's Strong Half-Year Performance Review

Updated Category News Views 95

Overview of Albion KAY VCT PLC Albion KAY VCT PLC plays a critical role in the investment landscape. The Company has recently published its Half-yearly Financial Report, which has garnered significant interest from both shareholders and potential investors. This report provides an in-depth look at the Company’s operations and financial condition over the six months...

Continue Reading
BlackRock Inc. Acknowledges Significant Stake in Syensqo

Updated Category News Views 160

Participation Notification by BlackRock Inc. In a recent communication, BlackRock Inc. has informed Syensqo of their increase in voting rights ownership, surpassing the critical threshold of 3%. This change is attributed to recent acquisitions or disposals of voting securities, which is in line with European transparency regulations. Details of the Notification The...

Continue Reading
Black Kite Unveils Innovative Global AI Risk Assessment Nexus

Updated Category News Views 204

Black Kite Launches Groundbreaking AI Assessment Framework Black Kite's GA³™ framework addresses a significant void in current global assurance frameworks. It creates a comprehensive standard that adapts to the ever-changing AI threat landscape. Importance of AI Risk Management Frameworks As cyber threats evolve, organizations face challenges in third-party risk...

Continue Reading
Purdue University Leads All-Boilermaker Mission with Virgin Galactic

Updated Category News Views 255

Purdue University Embarks on a Landmark Space Mission Building upon its rich legacy in space exploration, Purdue University is poised to undertake a remarkable journey — an all-Boilermaker crew will participate in a Virgin Galactic suborbital spaceflight known as Purdue 1. Set to launch in the near future, this mission opens up new avenues for academic exploration in...

Continue Reading
LP Building Solutions Provides Update on Q3 2024 Earnings Call

Updated Category News Views 77

LP Building Solutions Reveals Q3 2024 Earnings Call Details LP Building Solutions (NYSE: LPX), a prominent player in the building materials sector, has officially announced the schedule for its earnings conference call, set for an upcoming Tuesday. This anticipated event will highlight the financial results for the third quarter of 2024. Important Conference Call...

Continue Reading